These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5002483)

  • 1. Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man.
    Hucker HB; Grady LT; Michniewicz BM; Stauffer SC; White SE; Maha GE; McMahon FG
    J Pharmacol Exp Ther; 1971 Nov; 179(2):359-71. PubMed ID: 5002483
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man.
    Vickers S; Stuart EK; Bianchine JR; Hucker HB; Jaffe ME; Rhodes RE; Vandenheuvel WJ
    Drug Metab Dispos; 1974; 2(1):9-22. PubMed ID: 4150141
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotransformation of diphenoxylate in rat and dog.
    Karim A; Garden G; Trager W
    J Pharmacol Exp Ther; 1971 Jun; 177(3):546-55. PubMed ID: 5568810
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of tinidazole in the rat and dog.
    Wood BA; Rycroft D; Monro AM
    Xenobiotica; 1973 Dec; 3(12):801-12. PubMed ID: 4786681
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
    Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-oxazole-4-acetate, a new hypolipidemic agent, in the rat, rabbit, and dog. Glucuronidation of carboxyl group and cleavage of furan ring.
    Kobayashi T; Ando H; Sugihara J; Harigaya S
    Drug Metab Dispos; 1987; 15(2):262-6. PubMed ID: 2882988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological disposition and plasma metabolites of a new anti-inflammatory agent, diftalone, in rat, dog, monkey and man.
    Benedetti MS; Assandri A; Schelling JL; Villani F
    Arzneimittelforschung; 1977; 27(12):2364-8. PubMed ID: 414763
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of diazoxide in man and experimental animals.
    Pruitt AW; Faraj BA; Dayton PG
    J Pharmacol Exp Ther; 1974 Jan; 188(1):248-56. PubMed ID: 4203373
    [No Abstract]   [Full Text] [Related]  

  • 10. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man.
    Hucker HB; Stauffer SC; White SD; Rhodes RE; Arison BH; Umbenhauer ER; Bower RJ; McMahon FG
    Drug Metab Dispos; 1973; 1(6):721-36. PubMed ID: 4156293
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of l-N-benzyl- -methoxy-3-trifluoromethylphenethylamine hydrochloride in the rat, dog, monkey and man.
    Intoccia AP; Hwang B; Joseph G; Konicki G; Walkenstein SS
    Neuropharmacology; 1972 Nov; 11(6):761-75. PubMed ID: 4629346
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of cefazedone in Wistar rat, beagle dog and rhesus monkey.
    Sailer H; Diekmann HW; Faro HP; Garbe A
    Arzneimittelforschung; 1979; 29(2a):404-11. PubMed ID: 114189
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of 2-benzylthio-5-trifluoromethyl benzoic acid (BTBA) by the rat, dog and man.
    Taylor JA
    Xenobiotica; 1973 Mar; 3(3):151-64. PubMed ID: 4729681
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug.
    Noda K; Noguchi H; Okui M; Tada K; Morimoto Y
    Arzneimittelforschung; 1972 Apr; 22(4):732-43. PubMed ID: 4626080
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.
    Hayes A; Cooper RG
    J Pharmacol Exp Ther; 1971 Feb; 176(2):302-11. PubMed ID: 4998689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of Morocromen in animals and man (author's transl)].
    Dell HD; Jacobi H; Kamp R; Lorenz D
    Arzneimittelforschung; 1982; 32(5):492-8. PubMed ID: 7201825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition and metabolism of 5-(4,5-dihydro-2-phenylbenz[e]indol-3-yl)salicylic acid (fendosal) in the rat, mouse, rabbit, do, rhesus monkey, and man.
    Warrander A; Metcalf R; Fromson JM
    Drug Metab Dispos; 1981; 9(2):161-7. PubMed ID: 6113117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
    Housholder GE; Loo TL
    J Pharmacol Exp Ther; 1971 Nov; 179(2):386-95. PubMed ID: 5133607
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological disposition and metabolic fate of fluphenazine- 14 C in the dog and rhesus monkey.
    Dreyfuss J; Ross JJ; Schreiber EC
    J Pharm Sci; 1971 Jun; 60(6):821-5. PubMed ID: 5001926
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
    Glazko AJ
    Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.